These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 31857716)
1. Type 1 IGF receptor associates with adverse outcome and cellular radioresistance in paediatric high-grade glioma. Simpson AD; Soo YWJ; Rieunier G; Aleksic T; Ansorge O; Jones C; Macaulay VM Br J Cancer; 2020 Mar; 122(5):624-629. PubMed ID: 31857716 [TBL] [Abstract][Full Text] [Related]
2. Dual targeting of IGF-1R and PDGFR inhibits proliferation in high-grade gliomas cells and induces radiosensitivity in JNK-1 expressing cells. Carapancea M; Cosaceanu D; Budiu R; Kwiecinska A; Tataranu L; Ciubotaru V; Alexandru O; Banita M; Pisoschi C; Bäcklund ML; Lewensohn R; Dricu A J Neurooncol; 2007 Dec; 85(3):245-54. PubMed ID: 17568996 [TBL] [Abstract][Full Text] [Related]
3. Type 1 IGF Receptor Localization in Paediatric Gliomas: Significant Association with WHO Grading and Clinical Outcome. Clément F; Martin A; Venara M; de Luján Calcagno M; Mathó C; Maglio S; Lombardi MG; Bergadá I; Pennisi PA Horm Cancer; 2018 Jun; 9(3):205-214. PubMed ID: 29524179 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R. Guo T; Feng Y; Liu Q; Yang X; Jiang T; Chen Y; Zhang Q Tumour Biol; 2014 Nov; 35(11):11269-75. PubMed ID: 25117070 [TBL] [Abstract][Full Text] [Related]
5. Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor. Bayin NS; Ma L; Thomas C; Baitalmal R; Sure A; Fansiwala K; Bustoros M; Golfinos JG; Pacione D; Snuderl M; Zagzag D; Barcellos-Hoff MH; Placantonakis D Neoplasia; 2016 Dec; 18(12):795-805. PubMed ID: 27978994 [TBL] [Abstract][Full Text] [Related]
6. IRS2 copy number gain, KRAS and BRAF mutation status as predictive biomarkers for response to the IGF-1R/IR inhibitor BMS-754807 in colorectal cancer cell lines. Huang F; Chang H; Greer A; Hillerman S; Reeves KA; Hurlburt W; Cogswell J; Patel D; Qi Z; Fairchild C; Ryseck RP; Wong TW; Finckenstein FG; Jackson J; Carboni JM Mol Cancer Ther; 2015 Feb; 14(2):620-30. PubMed ID: 25527633 [TBL] [Abstract][Full Text] [Related]
7. MiRNA-323-5p Promotes U373 Cell Apoptosis by Reducing IGF-1R. Yang HA; Wang X; Ding F; Pang Q Med Sci Monit; 2015 Dec; 21():3880-6. PubMed ID: 26656446 [TBL] [Abstract][Full Text] [Related]
8. IGF-1R depletion sensitizes colon cancer cell lines to radiotherapy. Zong R; Chen X; Feng J; Xu S Cancer Biomark; 2021; 32(2):199-206. PubMed ID: 34092618 [TBL] [Abstract][Full Text] [Related]
9. IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination. Chitnis MM; Lodhia KA; Aleksic T; Gao S; Protheroe AS; Macaulay VM Oncogene; 2014 Nov; 33(45):5262-73. PubMed ID: 24186206 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit. Raju U; Molkentine DP; Valdecanas DR; Deorukhkar A; Mason KA; Buchholz TA; Meyn RE; Ang KK; Skinner H Cancer Med; 2015 Jan; 4(1):65-74. PubMed ID: 25355701 [TBL] [Abstract][Full Text] [Related]
11. The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma. Alexandru O; Purcaru SO; Tataranu LG; Lucan L; Castro J; Folcuţi C; Artene SA; Tuţă C; Dricu A Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29329222 [TBL] [Abstract][Full Text] [Related]
12. GSK1838705A, an IGF-1R inhibitor, inhibits glioma cell proliferation and suppresses tumor growth in vivo. Zhou X; Shen F; Ma P; Hui H; Pei S; Chen M; Wang Z; Zhou W; Jin B Mol Med Rep; 2015 Oct; 12(4):5641-6. PubMed ID: 26238593 [TBL] [Abstract][Full Text] [Related]
13. Targeting the IGF-Axis in Cultured Pediatric High-Grade Glioma Cells Inhibits Cell Cycle Progression and Survival. Chen YM; Leibovitch M; Zeinieh M; Jabado N; Brodt P Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259440 [TBL] [Abstract][Full Text] [Related]
14. Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways. Dayyani F; Parikh NU; Varkaris AS; Song JH; Moorthy S; Chatterji T; Maity SN; Wolfe AR; Carboni JM; Gottardis MM; Logothetis CJ; Gallick GE PLoS One; 2012; 7(12):e51189. PubMed ID: 23300537 [TBL] [Abstract][Full Text] [Related]
15. Radioresistant laryngeal cancers upregulate type 1 IGF receptor and exhibit increased cellular dependence on IGF and EGF signalling. Qureishi A; Rieunier G; Shah KA; Aleksic T; Winter SC; Møller H; Macaulay VM Clin Otolaryngol; 2019 Nov; 44(6):1026-1036. PubMed ID: 31536667 [TBL] [Abstract][Full Text] [Related]
16. IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma. Wan X; Yeung C; Heske C; Mendoza A; Helman LJ Neoplasia; 2015 Apr; 17(4):358-66. PubMed ID: 25925378 [TBL] [Abstract][Full Text] [Related]